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Abstract
Background: Estrogens have neuroprotective properties. The aim of the study was to assess the impact of an
isopropanolic extract of Cimicifuga racemosa (iCR), 17ß-estradiol (E2), testosterone (T) and Tibolone’s 3α-OH
metabolite (Org4094) on local estrogen formation in hippocampus tissue from non-human primates ex vivo in vitro
and human neuroblastoma cells (SH-SY5Y) in vitro.
Methods: SH-SY5Y cells were incubated in RPMI 1640 medium containing 5 % steroid-depleted fetal calf serum for
3 days, and subsequently incubated in absence or presence of iCR at 10 μg/ml (n = 5) and 1 μg/ml (n = 5), E2 at 10
−8 M (n = 5), and 10−6 M (n = 5), or T at 10−8 M (n = 5), and 10−6 M (n = 5), respectively, at 37 °C for either 24 h or
directly in cell extracts. Hippocampus tissue from healthy female cynomolgus macaques (n = 14) was homogenized
and treated with iCR, E2 and Org4049 accordingly. STS activity was evaluated by incubating homogenized brain
cells and tissue with [3H]-estrone sulfate and separating the products estrone (E1) and E2 by thin layer
chromatography. STS activity was expressed as total estrogen formation (E1 + E2) fmol/mg of protein/min. Statistical
comparisons were made using unpaired T-Test for comparing two sets of data and ANOVA to compare many
groups at once. A p value < 0.05 was considered to be significant different.
Results: Basal total estrogen formation was significantly higher in proliferative SH-SY5Y cells (1350.06 ± 109 E1 + E2
fmol/mg of protein/min) compared to hippocampus tissue (37.83 ± 3.9 E1 + E2 fmol/mg of protein/min; p < 0.01).
ICR exerted a bidirectional action with an immediate strong inhibitory effect being followed by a stimulation of STS
activity (85 % increase). E2 had a bidirectional dose-dependent long-term effect on STS activity (−23 % reduction
and 18 % increase). T and Org4094 had an immediate strong inhibitory effect on STS activity that further
maintained with 24 h T treatment (30 % decrease).
Conclusions: Local estrogen formation within brain cells and tissue may be modulated by black cohosh, 17ß-estradiol,
testosterone, and Tibolone’s 3α-OH metabolite, respectively. The clinical implication of this finding has to be elucidated.
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Background
The sex steroid 17β-Estradiol (E2) displays neuro-
protective and -reparative properties by, e.g. promoting
neuronal survival, neuritogenesis and synaptic function,
reducing local inflammation of astrocytes and microglia,
and facilitating remyelination, respectively [1]. Specific-
ally, estrogens seem to display these characteristics when
initiated during the critical window of opportunity close
to menopause [2]. Brain, as other tissues, possesses the
enzymes necessary for local formation of active hor-
mones, neurosteroids, from inactive precursor hor-
mones. They predominantly use (non-genomic)
signaling pathways common for neuromodulators such
as modulating the activity of several neurotransmitter re-
ceptors. Neurosteroids occur as free unconjugated ste-
roids, sulfate esters or fatty acids esters [3]. Conjugated
and unconjugated neurosteroids differ in their metabolic,
behavioral and psychological effects, e.g. in cognition [4].
Thus, the enzyme steroid sulfatase (STS) plays a major
role as it regulates the equilibrium between sulfated and
free neuroactive steroids in the brain [5]. An imbalance
in the ratio of unconjugated steroid/steroid sulfate has
been shown to have an impact on memory and longterm
potentiation in the hippocampus [6, 7]. Interestingly, in-
creased dehydroepiandrosterone sulfate (DHEAS) rather
than DHEA level has been found to enhance memory
possibly by positively influencing brain cholinergic func-
tion [8, 9] and decreasing ϒ-amino butyrate (GABAA)-
ergic receptor activity [10]. In contrast, unconjugated
neurosteroids are thought to act on GABAA receptors as
positive modulators [11].
The risk of cognitive decline increases with age. Thus,
menopausal hormone therapy (MHT) containing estro-
gens, androgens or the synthetic steroid tibolone, re-
spectively, would be expected to have a positive impact
on cognition. However, so far MHT has yielded conflict-
ing results and is not recommended for dementia pre-
vention [12, 13]. Herbs such as black cohosh are also
frequently used for vasomotor symptom relief in meno-
pausal women. There is some evidence that black co-
hosh has some neuroprotective effects [14].
Under the hypothesis that an increase of local estrogen
formation has a positive impact on memory, the aim of
our study was to investigate the effect of black cohosh
on STS enzyme activity in hippocampus tissue ex vitro
in vivo and neurons in vitro, respectively, in comparison
to E2, T, and an estrogenic metabolite of tibolone.
Methods
Chemical, reagents, and steroids
The iCR (B. Nr. 010720) was provided by Schaper &
Bruemmer GmbH & Co.KG. Salzgitter, Germany. The
concentration of the extract was 100 mg/ml in relation
to the dry residue. Alcohol concentration was 40 % (v/
v). Tibolone’s 3α-OH metabolite (Org4094) was pro-
vided by NV Organon (Oss, the Netherlands). The
radioactive labeled steroid [3H]-E1S (specific activity
57.3 Ci/mmol) was purchased from Perkin Elmer Life
and Analytical Sciences (549 Albany Street, Boston, MA,
USA). Unlabeled E2 and E1 were obtained from Sigma.
Unless stated otherwise, all chemicals were from Sigma–
Aldrich® (Deisenhofen, Germany).
Neuroblastoma cells and hippocampus tissue
The human neuroblastoma cell line SH-SY5Y was pur-
chased from the Leibniz Institute DSMZ-German Col-
lection of Microorganisms and Cell Cultures (DSMZ; no
ACC 209). Hippocampus tissues were used from lactat-
ing female control cynomolgus monkeys (Macaca fasci-
cularis) that were euthanized in the course of other
experiments. In brief, 14 adult female cynomolgus ma-
caques ranging from 4 to 8 years of age were obtained
from Vietnam (n = 5) and Mauritius (n = 9), respectively.
Each animal was clinically evaluated and determined to
be in good health. In order to monitor the welfare of an
individual or a group of animals, additional observations
to those already detailed were instigated at the discretion
of the study director. In certain instances this included
treatment as advised by a Covance veterinary surgeon.
Animals were kept according to the German Animal
Protection Law ("Tierschutzgesetz"), dated 25 May 1998.
Study procedures
SH-SY5Y cells were cultured in RPMI 1640 medium
(Gibco, Karlsruhe, Germany) containing 10 % fetal calf
serum (FCS; PAA, Coelbe, Germany), 2 mML glutamine
and 1 % penicillin-streptomycin, in an atmosphere con-
taining 5 % CO2 and 95 % air at 37 °C. Prior to and dur-
ing treatments, 5 % dextran-coated charcoal (DCC)
steroid-depleted fetal calf serum (FCS) was used. Hippo-
campus tissues from non-human primates were removed
during necropsy, washed with 0.06 M Tris–HCl buffer
pH 7.0, immediately frozen in liquid nitrogen, and kept
at −70 °C until analysis. Black cohosh (iCR) and steroids
(E2, T, Org4094) were added from stock solutions and
diluted in culture medium resulting in a final concentra-
tion of less than 0.5 % isopropanol (iCR) and 0.1 % etha-
nol (hormones), respectively. The same concentration of
isopropanol and ethanol was present in the control sam-
ples, respectively. The medium containing fresh iCR and
steroids was replaced every 2 days. ICR was used at a
concentration of 10 μg/ml and 1 μg/ml, whereas E2, T
and Org4094 were used at a concentration of 10−8 and
10−6 M, respectively. Neuroblastoma cells were incu-
bated in RPMI 1640 medium containing 5 % steroid-
depleted FCS for 3 days, and subsequently incubated in
the presence or absence of iCR and steroids for either
24 h, or enzyme activity was determined directly in cell
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extracts (“direct”). In hippocampus tissue, enzyme activ-
ity was measured directly (“direct“) after incubation with
the respective substance.
E1S-sulfatase (STS) activity assay
STS activity was measured as described previously
[15]. In brief, SH-SY5Y cells were homogenized on
ice, in 2 ml 0.06 M Tris–HCl-buffer pH 7.0 (assay
buffer throughout the entire procedure) for approxi-
mately 1 min at maximum speed using a Polytron®
homogenizer (Kinematica, AG). Hippocampus tissue
(2 mg) was finely minced with scissors and homoge-
nized accordingly. All incubations were carried out in
duplicate. The incubation mixtures consisted of
200 μl homogenate, 19.39 pmol [3H]-E1S in 100 μl of
buffer, and 100 μg of NADH and NADPH in 100 μl
of buffer (total incubation volume 400 μl). Simultan-
eous background incubations using buffer instead of
cell and tissue homogenate, respectively, were per-
formed in order to correct for non-enzymatic trans-
formation of the substrate. After 15 min of
incubation in air at 37 °C in a water bath, 200 μg of
non-radioactive E1 and E2 were added in 100 μl of
ethanol together with 0.5 ml of 0.5 M sodium phos-
phate buffer, pH 7.0. The unconjugated steroids were
extracted with 2.0 ml toluene. After inverting the
tubes 100 times they were centrifuged at 1500 × g for
10 min. The lower aqueous phase was frozen in li-
quid nitrogen Folch-Solution (2:1 chloroform:metha-
nol). Thin layer chromatography (TLC) on Alugram
Sil G/UV 254 (Roth; Macherey-Nagel Düren,
Germany) was performed using 13 % ethanol in tolu-
ene as solvent. After visualization in 254 nm UV
light, the zones in the plate corresponding to the es-
trogens as well as the non-fluorescent zones were cut
apart and separately eluted with 3 ml ethanol and
6 ml scintillation fluid. Aliquots were taken from each
fraction from the TLC plate for counting of the [3H]
activity. A Wallac 1409 (ß-Counter) scintillation spec-
trometer was used for the radioactivity measurements
and Riafluor® (New EnglandNuclear Corporation, Bos-
ton, MA, USA) was used as scintillation fluid. The
enzyme activity was expressed as the amount of un-
conjugated estrogen (E1 + E2) formed per minute and
per milligram of protein (E1 + E2 fmol/mg of protein/
min). The total protein was determined by the
method of Bradford [16].
Statistical methods
Results were expressed as the mean ± standard error of
the mean (S.E.M.). Statistical comparisons were made
using unpaired T-Test for comparing two sets of data
and ANOVA to compare many groups at once. A p
value < 0.05 was considered to be significant different.
All cell culture treatment experiments were repeated
four times. Negative STS activity values were set to zero
and repeated measures were aggregated by calculating
the mean.
Results
Basal estrogen formation as indicative for brain STS
activity
Basal E1, E2 and total estrogen formation (E1 + E2) were
assessed in untreated SH-SY5Y cells and hippocampus
tissue of non-human primates. Irrespective of incubation
duration (“direct“, “24 h“), E2 was the most abundant la-
beled estrogen found after incubation with labeled E1S.
On average, the concentration of locally formed E2 was
about 22 times (SH-SY5Y cells) and 12 times (hippocam-
pus) higher than that of E1, respectively. In SH-SY5Y
cells, mean basal total estrogen formation (E1 + E2) did
not differ between “direct” and “24 h” incubation (“dir-
ect”: 1350.06 ± 109 fmol/mg of protein/min (n = 15) vs.
“24 h“: 1515.87 ± 72 fmol/mg of protein/min (n = 10);
p > 0.06). However, the corresponding value from hippo-
campus tissue (n = 14) after „direct“incubation was
37.83 ± 3.9 E1 + E2 fmol/mg of protein/min, thus being
significantly lower than basal total estrogen formation in
SH-SY5Y cells (p < 0.01). For comparison between
groups, the respective control levels of basal total estro-
gen formation (E1 + E2) were set to 100 % and the per-
centage changes after „direct“or “24 h“treatment with
iCR, E2, T, and Org4094 were calculated.
Impact of black cohosh on brain STS activity
„Direct“incubation with iCR at 10 μg/ml and 1 μg/ml
significantly decreased STS activity (E1 + E2 formation/
mg of protein/min) in SH-SY5Y cells (n = 5) and hippo-
campus tissue (n = 14) in a dose-dependent manner (p <
0.01) (Fig. 1). The inhibitory effect was significantly
more pronounced in proliferative SH-SY5Y cells com-
pared to hippocampus tissue (p < 0.01). However, in SH-
SY5Y cells (n = 5) after “24 h“incubation with iCR total
estrogen formation (E1 + E2) significantly increased al-
most reaching baseline levels again for iCR at 1 μg/ml.
In cells treated with iCR at 10 μg/ml for “24 h“total es-
trogen formation (E1 + E2) significantly exceeded base-
line levels by 85 % (p < 0.001). The dose-dependent
difference in total estrogen formation after “24 h” was
significant (p < 0.01).
Impact of selected steroids on brain STS activity
In a next step, SH-SY5Y cells (n = 5) and hippocampus
tissue (n = 3) were treated with E2 at 10−6 M and 10−8
M, respectively (Fig. 2). „Direct“incubation with E2 did
not have a significant impact on total estrogen formation
(E1 + E2) in SH-SY5Y cells but slightly albeit significantly
reduced STS activity in hippocampus tissue by 6 % at 10
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−8 M (p < 0.01). The inhibitory effect became more pro-
nounced after “24 h“incubation with E2 at 10−6 M in
SH-SY5Y cells revealing a STS activity reduction by 23 %
(p < 0.001). However, E2 at 10−8 M had an opposite effect
as it significantly increased STS activity by 18 % (p < 0.001).
In an exploratory attempt, SH-SY5Y cells (n = 5) and
hippocampus tissue (n = 3) were treated with either T or
Org4049 at 10−6 M and 10−8 M, respectively (Fig. 3).
„Direct“incubation with T at 10−6M and 10−8 M had op-
posed effects on STS activity in SH-SY5Y cells. T at the
higher concentration significantly decreased STS activity
by about 88 % (p < 0.001), while the lower concentration
led to a non-significant 16 % increase compared to base-
line activity (p = 0.09). After “24 h“incubation with T, ei-
ther concentration significantly decreased total estrogen
formation (E1 + E2) by about 30 % (p < 0.001). In hippo-
campus tissue, Org4094 significantly reduced STS activity
in a dose-dependent manner (p < 0.05).
When comparing the impact of different compounds
on hippocampus tissue (Fig. 4), total estrogen formation
(E1 + E2) was lowest after treatment with Org4040 at 10
−6 M, highest after treatment with E2 (10−6 and 10−8 M),
and in-between with iCR treatment, respectively (iCR at
1 μg/ml vs. E2 at 10−6 / 10−8 M; p < 0.001).
Fig. 1 Impact of black cohosh (iCR) on STS activity in SH-SY5Y cells (n = 5) and hippocampus tissue from non-human primates (n = 14). Data are
presented as percentage change from control. Abbreviations: *p < 0.01 from controls; #p < 0.01 hippocampus vs. SH-SY5Y
Fig. 2 Impact of estradiol (E2) on STS activity in SH-SY5Y cells (n = 5) and hippocampus tissue from non-human primates (n = 3). Data are presented as
percentage change from control. Abbreviations: * = p < 0.01 from controls
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When comparing the impact of iCR, E2 and T on
total estrogen formation (E1 + E2) in SH-SY5Y cells,
significant treatment differences almost only oc-
curred for “direct” incubation. In detail, iCR at 1 μg/
ml had a significantly stronger inhibitory effect on
STS activity compared to E2 at 10−6 M and T at 10
−6 and 10−8 M, respectively (p < 0.001). In contrast,
total estrogen formation was significantly lower after
“24 h” incubation with T at 10−6 and 10−8 M com-
pared to iCR at 1 μg/ml (p < 0.001). Accordingly,
there were no significant differences in total estrogen
formation when comparing the effect of E2 and T;
neither during “direct” nor during “24 h” incubation.
Discussion
To our knowledge, we are the first to report on the im-
pact of black cohosh (iCR), 17ß-estradiol (E2), testoster-
one (T) and Tibolone’s 3α-OH metabolite (Org4049) on
brain STS activity in proliferative human neuroblastoma
cells in vitro and benign hippocampus tissue from non-
human primates ex vivo in vitro. We found that 1) both,
SH-SY5Y cells and hippocampus tissue, possessed the
enzymes necessary (at least STS, 17βHSD1) to produce
E2 from E1S, 2) total estrogen formation (E1 + E2) was
significantly higher in proliferative SH-SY5Y cells com-
pared to benign hippocampus tissue, 3) iCR exerted a bi-
directional action that was an immediate strong
Fig. 3 Impact of testosterone (T) and Org4049 on STS activity in SH-SY5Y cells (n = 5) or hippocampus tissue from non-human primates (n = 3).
Data are presented as percentage change from control. Abbreviations: * = p < 0.01 from controls
Fig. 4 Comparison of effects of iCR, E2 and Org 4094 on STS activity in hippocampus tissue. Data are presented as percentage change from
control. Abbreviations: * = p < 0.001 from controls; ** = p < 0.05 from controls
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inhibitory effect followed by a stimulation of STS activity
(85 % increase), 4) E2 had a bidirectional dose-
dependent long-term effect on STS activity (−23 % re-
duction and 18 % increase) with the latter being less
pronounced compared to iCR, 5) similar to iCR, T and
Org4094 had an immediate strong inhibitory effect on
STS activity that was, however, further maintained with
24 h T treatment (30 % decrease), and 6) differences in
treatment effects mainly occurred after “direct” incuba-
tion and were less pronounced in the long-term.
Proliferative human neuroblastoma SH-SY5Y cells
were originally derived from a metastatic bone tumor bi-
opsy and behave therefore like malignant tumor cells.
On the contrary, brain tissue from healthy animals con-
tains differentiated non-proliferative neurons.
Our finding that STS activity was higher in malignant
than healthy cells and tissue, respectively, is in accord-
ance with previous studies in breast cells [15] and brain
tumors [17]. Other factors might also contribute to the
differences observed such as species (human vs. mon-
key), origin of investigated material (SH-SY5Y cells ob-
tained from bone marrow biopsy vs. hippocampus tissue
obtained from brain necropsy), culture conditions (cells
vs. tissue), and the hormonal environment. However, the
latter possibly does not have a major impact since the
hormonal environment was expected to be low-
estrogenic in both, SH-SY5Y cells (obtained from a pre-
pubertal girl) and hippocampus tissue (obtained from
lactating monkeys).
“Direct” incubation, which eliminates cellular regula-
tion of metabolism, led to a reduction of estrogen bio-
synthesis regardless of treatment. By “direct” incubation,
we believe to obtain more valid information about regu-
lation of the selected compounds at the level of the
enzyme's catalytic activity. Our findings in brain are in
agreement with previous studies in malignant breast
cells and normal mammary gland, demonstrating an in-
hibitory effect on STS activity after “direct” incubation
by iCR [18], E2 [15], T [19] and Org4094 [15],
respectively.
In contrast, longer incubation in intact cells and tis-
sues also includes complex effects on STS expression,
and on downstream processing of metabolites, making it
difficult to differentiate between the respective effects.
Accordingly, “24 h” incubation with the respective com-
pounds yielded different results being either inhibitory
on STS activity (E2, T, Org4094) or stimulating (iCR,
E2), respectively. In brain tissue a positive increase in
STS activity would be expected to be more beneficial
promoting the reported neuro-protective and –repara-
tive effects [1].
Black cohosh, specifically, iCR has been shown to have
an impact on brain via modulating neurotransmitter re-
ceptors in vitro [20–23] and in vivo in rodents [14, 24]
as well as in humans [25, 26]. There is pharmacody-
namic evidence for bioactivity of iCR-ingredients in
brain in vivo, i.e. passing of the blood brain barrier. Dur-
ing menopause, the decline of circulating estrogens coin-
cidences with the decline of brain bioenergetics and a
shift towards a metabolically compromised phenotype
[27]. Oral administration of iCR or E2 for 1 week to
ovariectomized rats was able to restore neuronal excit-
ability leading to functional recovery of hypothalamic ac-
tivity [14, 24]. Furthermore, iCR has been shown to up-
regulate genes related to cell survival under metabolic
stress such as hypoxia [28–30]. In hypoestrogenic
women, the cerebral blood flow has been shown to be
reduced with regional patterns resembling those of pa-
tients with mild to moderate Alzheimer’s disease [31].
This mechanism has been hypothesized be the initiating
event in the metabolic process that results in dementia
of the Alzheimer's type, and thus may serve as the link
between hypoestrogenism and neurodegenerative
diseases.
E2 has been shown to display beneficial effects on the
entire bioenergetic system of the brain, e.g., from glucose
transport into cells to glycolysis, and ATP production
[27, 32]. Recent evidence is pointing to the mitochon-
drial respiratory chain as a novel and important target
for the actions of E2 and its receptors (ER), especially in
cells and tissues with high demands for mitochondrial
energy metabolism [33]. This E2-mediated pathway in-
volves the cooperation of both, nuclear and mitochon-
drial ERα and ERβ, and their co-activators for the
regulation of both, nuclear DNA- and mitochondrial
DNA-encoded genes for the mitochondrial respiratory
chain proteins [33]. Stimulation of the E2/ER-mediated
mitochondrial respiratory chain pathway could be highly
beneficial in brain, whereas impairment could be caus-
ally related to the pathogenesis of neurodegenerative/
cognitive disorders [33, 34].
Our study has some limitations. We were only able to
examine hippocampus tissue and not other regions in-
volved in cognition. Similarly, due to limited tissue avail-
ability, we could only assess STS activity, but not other
enzymes. Given the opposing effect of conjugated and
unconjugated neurosteroids on neurotransmitter signal-
ing the comparison of the expression of the e.g. GABAA
signaling cascade components before and after treatment
would have been of interest. We also acknowledge that
within brain tissue there are multiple cell types such as
astrocytes and microglia, oligodendrocytes, neurons as
well as blood vessels. Thus we cannot differentiate be-
tween their impacts on our results in hippocampus tis-
sue. However, this is why we included neuroblastoma
cells as model for a “single neuron system”.
Our results contribute to our previous work showing
that local STS activity can be modulated by exogenous
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steroids and black cohosh [15, 18, 19, 34] – also in brain
(this study). This might be one explanation as to how
those compounds frequently used in menopausal women
may affect cognition.
Conclusion
We showed that in vitro local estrogen formation within
brain cells and tissue was modulated by black cohosh
(iCR), 17ß-estradiol, testosterone, and Tibolone’s 3α-OH
metabolite, respectively. While short-term effects on
STS activity were different for the compounds studied,
the long-term effects in vitro were less pronounced be-
ing either inhibitory (E2, T, Org4094) or stimulating
(iCR, E2), respectively. The clinical implication of this
finding has to be elucidated.
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